Beta Thalassemia (HBB) Gene Sequencing with MCC is a comprehensive genetic test that analyzes the HBB (Hemoglobin Beta) gene to identify disease-causing variants associated with Beta Thalassemia. The test includes Maternal Cell Contamination (MCC) analysis, ensuring the accuracy of prenatal samples by detecting any maternal DNA contamination.
Test Purpose
Detects mutations in the HBB gene responsible for Beta Thalassemia.
Confirms diagnosis in individuals with suspected Beta Thalassemia.
Identifies carriers for family planning and reproductive counseling.
Supports prenatal diagnosis with MCC validation.
Helps assess the risk of passing the condition to future generations.
Who Should Consider This Test?
Individuals with unexplained anemia or abnormal hemoglobin results.
Couples planning pregnancy with a family history of Beta Thalassemia.
Partners of known Beta Thalassemia carriers.
Pregnant women undergoing prenatal genetic testing.
Families seeking genetic counseling.
Sample Required
Prenatal Samples: Chorionic Villus Sampling (CVS) or Amniotic Fluid